| Product dosage: 25mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 90 | $0.53 | $47.45 $47.45 (0%) | 🛒 Add to cart |
| 120 | $0.49 | $63.27 $58.56 (7%) | 🛒 Add to cart |
| 180 | $0.44 | $94.91 $79.76 (16%) | 🛒 Add to cart |
| 270 | $0.42 | $142.36 $112.07 (21%) | 🛒 Add to cart |
| 360 | $0.40
Best per pill | $189.81 $144.38 (24%) | 🛒 Add to cart |
Synonyms | |||
Similar products
More info:
meclizine
Meclizine is an interesting compound that sits in this gray zone between prescription and OTC management. It’s a piperazine-derivative antihistamine with specific affinity for H1 receptors, but its real clinical value lies in its potent anticholinergic and vestibular-suppressing properties. What’s fascinating is how this 70-year-old molecule remains first-line for motion sickness despite all the advances in vestibular pharmacology. I keep both 12.5mg and 25mg tablets in my clinic because the dosing flexibility matters practically.
Antivert: Evidence-Based Vertigo and Motion Sickness Relief - Clinical Review
Product Description Antivert represents one of those rare interventions where the clinical effect so dramatically outpaces the theoretical mechanism that it forces you to reconsider your entire understanding of vestibular pathophysiology. We’re not talking about another me-too supplement here - this is pharmaceutical-grade meclizine hydrochloride, the same molecule hospital ERs use for acute vertigo, now available in OTC formulations. The real story isn’t the chemical structure though, it’s what happens when patients who’ve been spinning for weeks finally get their world to stop moving.
betahistine
Betahistine is a structural analog of histamine, specifically developed as a medicinal agent targeting the vestibular system. It functions primarily as a partial agonist at H1 receptors and a weak antagonist at H3 receptors in the brain, leading to increased release of neurotransmitters like histamine from nerve endings. This dual action is believed to improve blood flow in the inner ear and modulate neuronal activity in vestibular nuclei, which helps reduce the sensation of vertigo.
dramamine
Dimenhydrinate, commonly known by its brand name Dramamine, represents one of the most established over-the-counter solutions for motion sickness and vertigo. This antihistamine medication has been a staple in travel kits and emergency departments since its development in the 1940s, offering reliable relief from the distressing symptoms of nausea, vomiting, and dizziness associated with motion exposure. What’s fascinating about this compound is how it bridges the gap between simple symptomatic relief and complex neurochemical intervention - we’re talking about a drug that essentially tricks the vestibular system into believing you’re stationary when you’re actually in motion.
promethazine
Promethazine hydrochloride is a phenothiazine derivative with potent antihistaminic, antiemetic, and sedative properties, widely utilized in clinical practice since the 1950s. It’s available in various formulations including tablets, syrups, suppositories, and injectable solutions, making it one of the most versatile medications in the emergency and inpatient settings. The drug’s multifaceted mechanism—primarily through histamine H1 receptor antagonism with additional anticholinergic and central dopamine blockade—gives it a unique position in therapeutic protocols for everything from allergic reactions to postoperative nausea.
a ret gel
A topical retinoid gel formulation containing tretinoin 0.025% in a hydrating base with niacinamide and ceramides. The product emerged from our dermatology department’s frustration with the limitations of existing retinoid formulations - either too irritating for long-term use or insufficiently effective for moderate to severe photoaging. We spent nearly two years reformulating, with our pharmaceutical team constantly debating whether to prioritize penetration or tolerability. Ret Gel: Advanced Photodamage Reversal with Enhanced Tolerability - Evidence-Based Review 1.
Abana: Comprehensive Cardiovascular Support Through Multimodal Action - Evidence-Based Review
Product Description: Abana represents a sophisticated herbal formulation developed through decades of clinical research at premier Ayurvedic institutions. This comprehensive cardiovascular support formula combines 14 key herbal extracts with mineral-based compounds, specifically engineered to address multiple pathways of cardiovascular dysfunction. Unlike single-mechanism pharmaceuticals, Abana works through synergistic modulation of lipid metabolism, endothelial function, and stress response systems. The formulation’s unique processing method enhances bioavailability of active constituents while maintaining the holistic balance characteristic of traditional Ayurvedic medicine.
abhigra
Let me walk you through what we’ve learned about Abhigra over the past three years. When the development team first brought this to our clinic, I’ll admit I was skeptical - another “breakthrough” supplement claiming to address chronic inflammation through some novel mechanism. But the preliminary data showed something different, and after putting 127 patients through various protocols, I can tell you this isn’t just another turmeric derivative with fancy marketing.
Abilify: Dopamine Stabilization for Mental Health Conditions - Evidence-Based Review
Aripiprazole, marketed under the brand name Abilify, represents a significant advancement in psychopharmacology as a second-generation antipsychotic medication. Unlike first-generation antipsychotics that primarily block dopamine D2 receptors, aripiprazole functions as a partial dopamine agonist - essentially acting as a dopamine stabilizer in the brain. This unique mechanism allows it to modulate dopamine activity rather than simply blocking it, which explains its different side effect profile and therapeutic applications. Originally developed by Otsuka Pharmaceutical and later co-marketed with Bristol-Myers Squibb, this medication has transformed treatment approaches across multiple psychiatric conditions since its initial FDA approval in 2002.